Nemaline MyopathySymptoms, Doctors, Treatments, Advances & More
Nemaline Myopathy Overview
Learn About Nemaline Myopathy
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Julien Ochala practices practicing medicine in Copenhagen, Denmark. Mr. Ochala is rated as an Elite expert by MediFind in the treatment of Nemaline Myopathy. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Nemaline Myopathy, Tubular Aggregate Myopathy, Congenital Fiber-Type Disproportion, and X-Linked Myotubular Myopathy.
Edna Hardeman practices practicing medicine in Sydney, Australia. Ms. Hardeman is rated as an Elite expert by MediFind in the treatment of Nemaline Myopathy. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Nemaline Myopathy, X-Linked Myotubular Myopathy, Congenital Fiber-Type Disproportion, and Tubular Aggregate Myopathy.
Kristen Nowak practices practicing medicine in Perth, Australia. Ms. Nowak is rated as an Elite expert by MediFind in the treatment of Nemaline Myopathy. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Nemaline Myopathy, Congenital Fiber-Type Disproportion, X-Linked Myotubular Myopathy, and Tubular Aggregate Myopathy.
Summary: In the Congenital Myopathy Research Program at Boston Children's Hospital and Harvard Medical School, the researchers are studying the congenital myopathies (neuromuscular diseases present from birth), including central core disease, centronuclear/myotubular myopathy, congenital fiber type disproportion, multiminicore disease, nemaline myopathy, rigid spine muscular dystrophy, SELENON (SEPN1), RYR...
Summary: The objective of this natural history study is to comprehensively characterize the disease progression and clinical features of nemaline myopathies. The study aims to establish a well-defined cohort of patients in Spain, enabling long-term follow-up and facilitating recruitment for future clinical trials.